Benefits of SGLT2i in heart failure across a broad range of ejection fractions: new opportunities and future challenges

被引：0
|
作者：
Volpe, Massimo [1 ]
Patrono, Carlo [2 ]
机构：
[1] Sapienza Univ Rome, St Andrea Hosp, Dept Cardiol, Rome, Italy
[2] Catholic Univ, Sch Med, Dept Pharmacol, Rome, Italy
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷 / 03期
关键词：
SACUBITRIL/VALSARTAN;
D O I：
10.1093/eurheartj/ehac649
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：178 / 179
页数：2
相关论文
共 50 条
  • [1] SGLT2i in heart failure: can their benefits be expanded across the entire spectrum of ejection fraction?
    Requena-Ibanez, Juan Antonio
    Santos-Gallego, Carlos G.
    Badimon, Juan Jose
    REVISTA ESPANOLA DE CARDIOLOGIA, 2022, 75 (10): : 833 - 841
  • [2] SGLT2i in heart failure with reduced ejection fraction: benefits in real life?
    Sanchez Gonzalez, V. Virtudes
    Flano-Lombardo, R.
    Esteve-Ruiz, I.
    Cortez, G.
    Aranda-Dios, A.
    Duran-Torralba, C.
    Rangel-Sousa, D.
    Sobrino-Marquez, J. M.
    Grande-Trillo, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 72 - 73
  • [3] SGLT-2I THERAPY IN HEART FAILURE : CHALLENGES AND OPPORTUNITIES
    Radhakrishna, A.
    Cusack, R.
    Barton, J.
    HEART, 2020, 106 : A16 - A17
  • [4] Time to SGLT2i Initiation in Patients With Heart Failure
    Moon, Jungyeon
    Udell, Jacob A.
    Chong, Alice
    Fang, Jiming
    Austin, Peter
    Ko, Dennis T.
    Stukel, Therese
    Atzema, Clare
    Booth, Gillian
    Tu, Karen
    Naimark, David
    Jackevicius, Cynthia
    CIRCULATION, 2023, 148
  • [5] ECHOCARDIOGRAPHIC FINDING BETWEEN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION IN TREATMENT WITH ARNI AND SGLT2I
    Ceci, Vincenzo
    Mazzeo, Pietro
    Ferrara, Salvatore
    Nardella, Luigi
    Tricarico, Lucia
    Alfieri, Simona
    Croella, Francesca
    Amatruda, Marco
    Granatiero, Michele
    D'alessandro, Damiano
    Di Nunno, Nicola
    Pugliese, Rosanna
    Noviello, Giulia
    Correale, Michele
    Stabile, Egenio
    Stabile, Eugenio
    Iacoviello, Massimo
    Di Biase, Matteo
    Brunetti, Natale D.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24
  • [6] Risk of genitourinary infection similar among SGLT2i in patients with heart failure and preserved ejection fraction
    Reactions Weekly, 2024, 2011 (1) : 10 - 10
  • [7] SGLT2i Use in Pediatric Heart Failure: Multicenter Study
    Butts, R.
    Nandi, D.
    Hong, B.
    Lorts, A.
    Profita, E.
    Spinner, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S149 - S149
  • [8] Impact of SGLT2i Use on Functional Capacity in Heart Failure
    Jang, J.
    Nativi-Nicolau, J.
    Yip, D.
    Patel, P.
    Leoni-Moreno, J.
    Goswami, R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S333 - S333
  • [9] SGLT2i and loop diuretic withdrawal or downtitration in heart failure
    Domingo, Mar
    Ruiz-Cueto, Maria
    Teis, Albert
    Lupon, Josep
    Alonso, Nuria
    Bayes-Genis, Antoni
    REVISTA ESPANOLA DE CARDIOLOGIA, 2023, 76 (11): : 943 - 945
  • [10] The Growing Case for Use of SGLT2i in Heart Failure Additional Benefits of Empagliflozin in a HFpEF Rodent Model
    Ha, Chae-Myeong
    Wende, Adam R.
    JACC-BASIC TO TRANSLATIONAL SCIENCE, 2019, 4 (01): : 38 - 40
12345